ZBP1 and colorectal cancer: Notably, ZBP1-mediated PANoptosis contributes to the toxic side effects in healthy tissues of colorectal cancer patients under DNA-damage therapies, suggesting ZBP1 can be a promising therapeutic target to alleviate chemotherapy-related side effects [133].